Influence of age on the absorption, metabolism, and excretion of cocoa flavanols in healthy subjects

Molecular Nutrition and Food Research

Volumn 59, Issue 8, 2015, Pages 1504-1512

  Rodriguez Mateos, Ana ^a,b   Cifuentes Gomez, Tania ^a   Gonzalez Salvador, Isidro ^a   Ottaviani, Javier I ^c   Schroeter, Hagen ^c   Kelm, Malte ^b   Heiss, Christian ^b   Spencer, Jeremy P E ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c MARS INC   (United States)

Author keywords

( ) Epicatechin; ADME; Age; Cocoa flavanols; Pharmacokinetics

Indexed keywords

THEOBROMA CACAO;

CATECHIN; EPICATECHIN SULFATE; EPICATECHIN-GLUCURONIDE; FLAVONOID; GAMMA-VALEROLACTONE; GLUCURONIDE; LACTONE; SULFATE;

ADOLESCENT; ADULT; AGED; AGING; ANALOGS AND DERIVATIVES; ANALYSIS; BEVERAGE; BLOOD; CACAO; CHEMISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; CROSSOVER PROCEDURE; HALF LIFE TIME; HUMAN; INTESTINE ABSORPTION; KINETICS; MALE; METABOLISM; METHYLATION; PATIENT DROPOUT; RANDOMIZED CONTROLLED TRIAL; STEREOISOMERISM; URINARY EXCRETION; URINE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; BEVERAGES; CACAO; CATECHIN; CROSS-OVER STUDIES; FLAVONOIDS; GLUCURONIDES; HALF-LIFE; HUMANS; INTESTINAL ABSORPTION; KINETICS; LACTONES; MALE; METHYLATION; PATIENT DROPOUTS; RENAL ELIMINATION; STEREOISOMERISM; SULFURIC ACID ESTERS; YOUNG ADULT;

EID: 84938500112     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500091     Document Type: Article

References (25)

1. Heiss, C., Keen, C. L., Kelm, M., Flavanols and cardiovascular disease prevention. Eur. Heart J. 2010, 31, 2583-2592.
2. Hooper, L., Kay, C., Abdelhamid, A., Kroon, P. A. et al., Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am. J. Clin. Nutr. 2012, 95, 740-751.
3. Otten, J., Hellwig, J., Meyers, L., Dietary Reference Intakes: The Essential Guide to Nutrient requirements. The National Academies Press, Washington DC 2006.
4. Actis-Goretta, L., Leveques, A., Giuffrida, F., Romanov-Michailidis, F. et al., Elucidation of (-)-epicatechin metabolites after ingestion of chocolate by healthy humans. Free Rad. Biol. Med. 2012, 53, 787-795.
5. Ottaviani, J. I., Momma, T. Y., Kuhnle, G. K., Keen, C. L., Schroeter, H., Structurally related (-)-epicatechin metabolites in humans: assessment using de novo chemically synthesized authentic standards. Free Rad. Biol. Med. 2012, 52, 1403-1412.
6. Ottaviani, J. I., Kwik-Uribe, C., Keen, C. L., Schroeter, H., Intake of dietary procyanidins does not contribute to the pool of circulating flavanols in humans. Am. J. Clin. Nutr. 2012, 95, 851-858.
7. Vertzoni, M. V., Archontaki, H. A., Galanopoulou, P., Development and optimization of a reversed-phase high-performance liquid chromatographic method for the determination of acetaminophen and its major metabolites in rabbit plasma and urine after a toxic dose. J. Pharm. Biomed. Anal. 2003, 32, 487-493.
8. FDA. Bioavailability and bioequivalence studies for orally administered drug products-general considerations. 2011.
9. Prescot, L.F. Paracetamol (Acetaminophen): A critical bibliographic review. Taylor and Francis, London 1996.
10. Del Rio D., Rodriguez-Mateos, A., Spencer, J.P., Tognolini, M., Borges, G., Crozier, A., Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid. Redox Signal. 2013, 18, 1818-1892.
11. Coresh, J., Astor, B.C., Greene, T., Eknoyan, G., Levey, A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am. J. Kidney Dis. 2003, 41:1-12.
12. Bartosch, S., Fite, A., Macfarlane, G. T., McMurdo, M. E., Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl. Environ. Microbiol. 2004, 70, 3575-3581.
13. Benno, Y., Endo, K., Mizutani, T., Namba, Y. et al., Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Appl. Environ. Microbiol. 1989, 55, 1100-1105.
14. Hayashi, H., Sakamoto, M., Kitahara, M., Benno, Y., Molecular analysis of fecal microbiota in elderly individuals using 16S rDNA library and T-RFLP. Microbiol. Immunol. 2003, 47, 557-570.
15. Mueller, S., Saunier, K., Hanisch, C., Norin, E. et al., Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl. Environ. Microbiol. 2006, 72, 1027-1033.
16. Tiihonen, K., Tynkkynen, S., Ouwehand, A., Ahlroos, T., Rautonen, N., The effect of ageing with and without non-steroidal anti-inflammatory drugs on gastrointestinal microbiology and immunology. Brit. J. Nutr. 2008, 100, 130-137.
17. He, F., Ouwehand, A. C., Isolauri, E., Hosoda, M. et al., Differences in composition and mucosal adhesion of bifidobacteria isolated from healthy adults and healthy seniors. Curr. Microbiol. 2001, 43, 351-354.
18. Hopkins, M. J., Sharp, R., Macfarlane, G. T., Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 2001, 48, 198-205.
19. Mitsuoka, T., Intestinal flora and aging. Nutr. Rev. 1992, 50, 438-446.
20. Jin, J. S., Hattori, M., Isolation and characterization of a human intestinal bacterium Eggerthella sp. CAT-1 capable of cleaving the C-ring of (+)-catechin and (-)-epicatechin, followed by p-dehydroxylation of the B-ring. Biol. Pharm. Bull. 2012, 35, 2252-2256.
21. Kutschera, M., Engst, W., Blaut, M., Braune, A., Isolation of catechin-converting human intestinal bacteria. J. Appl. Microbiol. 2011, 111, 165-175.
22. Heiss, C., Kleinbongard, P., Dejam, A., Perre, S. et al., Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J. Am. Coll. Cardiol. 2005, 46, 1276-1283.
23. Schroeter, H., Heiss, C., Balzer, J., Kleinbongard, P. et al., (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc. Natl. Acad. Sci. USA 2006, 103, 1024-1029.
24. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific opinion on the substantiation of a health claim related to cocoa flavanols and maintenance of normalendothelium-dependent vasodilation pursuant to Article 13(5) of Regulation (EC) No. 1924/2006. EFSA J. 2012, 10, 2809-2830.
25. Vogiatzoglou, A., Mulligan, A. A., Luben, R. N., Lentjes, M. A. et al., Assessment of the dietary intake of total flavan-3-ols, monomeric flavan-3-ols, proanthocyanidins and theaflavins in the European Union. Brit. J. Nutr. 2014, 111, 1463-1473.